Amgen | AMGN - Ebitda



Amgen reported $3.6B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Agios Pharmaceuticals USD -125797000 20.45M Jun/2025
ALKERMES USD 126.53M 105.32M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Exelixis USD 220.92M 26.71M Jun/2025
Genmab DKK 376M 172M Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Glaxosmithkline GBP 3.23B 1.54B Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Merck USD 7.74B 625M Mar/2025
Moderna USD -760000000 164M Jun/2025
Neurocrine Biosciences USD 152.9M 121.6M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Novartis USD 6.08B 739M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Takeda JPY 366.2B 238.06B Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025
Ultragenyx Pharmaceutical USD -91344000 35.09M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025